Proteome Sciences (GB:PRM) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Proteome Sciences PLC has reported a surge in customer engagement and service inquiries in 2024, including a significant contract from a US biopharmaceutical company. The firm is optimistic about returning to growth this year, bolstered by the launch of new proteomics services and expansion in the US. Proteome Sciences specializes in proteomics services for drug discovery and biomarker identification, with proprietary technologies like SysQuant® and TMT®MS2.
For further insights into GB:PRM stock, check out TipRanks’ Stock Analysis page.